Using IVR to Maintain ACS Patients on Best Practice Guidelines (IVR-ACS BPG)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2010 by Lawson Health Research Institute.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
University of Ottawa Heart Institute
Information provided by:
Lawson Health Research Institute
ClinicalTrials.gov Identifier:
NCT01260207
First received: December 13, 2010
Last updated: NA
Last verified: December 2010
History: No changes posted

December 13, 2010
December 13, 2010
January 2010
January 2012   (final data collection date for primary outcome measure)
Compliance with BPGs [ Time Frame: 1 Year ] [ Designated as safety issue: Yes ]
Same as current
No Changes Posted
Utilization of health care resources: emergency visits, unscheduled physician visits and hospitalization and patient satisfaction [ Time Frame: 1 Year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Using IVR to Maintain ACS Patients on Best Practice Guidelines
Using Interactive Voice Response to Improve Disease Management and Compliance With Acute Coronary Syndrome Best Practice Guidelines

The purpose of this study is to determine whether interactive voice response (IVR) technology can be used to bring post discharge care for acute coronary syndrome (ACS) closer to best practice guidelines (BPGs).

The study hypothesis is that ACS patients who are contacted by IVR technology will be more likely to receive care as recommended in the BPGs than those followed by usual care.

Acute coronary syndrome (ACS) is a significant public-health problem in Canada and worldwide with 20,000 Canadians dying of myocardial infarction and 42,000 dying of coronary artery disease in 1999. Large clinical trials have provided evidence for the development of standardized best practice guidelines (BPG) and compliance with these guidelines have significantly improved survival. Despite the development and dissemination of BPG, their application in patients with ACS is suboptimal. This randomized control trial will use 2 groups: IVR and usual care. Patients in the IVR group will receive 5 automated calls at 1,3,6,9 and 12 months consisting of predetermined questions related to medication management, smoking cessation, diet, exercise and education as recommended by the ACC/AHA BPG for ACS. Responses are captured in a database allowing for interventions to maintain patients on BPG as needed.

Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Acute Coronary Syndrome Medication Adherence
  • Other: IVR group
    Patients in this arm will receive IVR follow-up telephone calls at 1,3,6,9 and 12 months post-discharge consisting of predetermined questions related to medication management, smoking cessation, diet, exercise and education as recommended by the ACC/AHA BPG for ACS. Upon completion of the IVR follow-up, all patients will be called by a member of the clinical research staff and asked to complete a follow-up survey.
  • Other: Usual care
    Patients in this arm will not receive IVR follow-up. One year after discharge, all patients will be called by a member of the clinical research staff and asked to complete a follow-up survey.
  • Experimental: IVR group
    Intervention: Other: IVR group
  • No Intervention: Usual care
    Intervention: Other: Usual care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
3000
June 2012
January 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients discharged from LHSC with ACS (acute myocardial infarction, STEMI, NSTEMI or unstable angina)
  • Patients who have a land line telephone service at home
  • Patients who speak English

Exclusion Criteria:

  • Patients discharged to a care facility or transferred to another health care institution
  • Patients who cannot provide informed consent
Both
18 Years and older
No
Contact: Rosanna Turner, BA 519-685-8500 ext 36570 rosanna.turner@lhsc.on.ca
Contact: Grace-Ann Koops-Huygen, BSN 519-685-8500 ext 75986 GraceAnn.KoopsHuygen@lhsc.on.ca
Canada
 
NCT01260207
R-07-391
No
Neville G. Suskin, University of Western Ontario and London Health Sciences Centre
Lawson Health Research Institute
University of Ottawa Heart Institute
Principal Investigator: Neville G. Suskin, MBChB, MSc University of Western Ontario and London Health Sciences Centre
Lawson Health Research Institute
December 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP